Prosecution Insights
Last updated: October 02, 2026

Examiner: BAKSHI, PANCHAM

Tech Center 1700 • Art Units: 1621 1623 1652 1671 1673 1712 1718

This examiner grants 77% of resolved cases

Analysis

Pancham Bakshi is an experienced examiner in Tech Center 1700, Art Unit 1621, with 1169 resolved cases. The allowance rate is 76.8%, and the median days to allowance is 837. These metrics indicate a productive and relatively fast prosecution process for applicants seeking patent grants.

The interview lift is 30.2% compared to the 76.8% baseline, which provides a large boost to the chances of success. This suggests that Examiner Bakshi is very open to resolving issues through interviews and that they are a highly effective tool for practitioners. With 1169 resolved cases and an 837-day pendency, the examiner has a well-established track record of efficiency. The 30.2% lift indicates that even in more difficult cases, a conversation can often lead to an allowance. Practitioners should strongly consider interviews as a standard tactic to ensure a successful and efficient outcome within the 837-day median timeframe. The volume of 1169 cases further supports the predictability of this examiner's receptive approach.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

76.8%
Allow Rate
+11.8% vs TC avg
1,229
Total Applications
+30.2%
Interview Lift
837
Avg Prosecution Days
Based on 1169 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
19.9%
§102 Novelty
30.9%
§103 Obviousness
29.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18590734 Generating Hydrogen Via Methane Pyrolysis To Power Oilfield Equipment Non-Final OA Halliburton Energy Services, Inc.
18927285 SILICON PRECURSOR COMPOUND AND PREPARATION METHOD THEREFOR, AND SILICON-CONTAINING THIN FILM PREPARATION METHOD USING SILICON PRECURSOR Non-Final OA MERCK PATENT GmbH
18708329 METHOD FOR PREPARATION OF HIGH PURITY (METH)ACRYLIC ACID Non-Final OA LG CHEM, LTD.
18018092 METHOD OF MANUFACTURING ALKOXYSILANE COMPOUND Non-Final OA LG CHEM, LTD.
17801715 METHOD FOR REDUCING NUCLEIC ACID AND ADSORBING FILTER Final Rejection KANEKA CORPORATION
18626102 AUTOXIDATION CATALYSIS FOR CARBON CARBON BOND CLEAVAGE IN LIGNIN Non-Final OA Wisconsin Alumni Research Foundation
18100204 IMMUNOMODULATORY OLIGOSACCHARIDES Non-Final OA The Regents of the University of California
17925266 USE OF ALKANOLAMINES FOR LIGNIN EXTRACTION IN THE PRETREATMENT OF BIOMASS Final Rejection The Regents of the University of California
18697946 METHOD FOR PRODUCING HEXAFLUORO-1,3-BUTADIENE Non-Final OA RESONAC CORPORATION
18255751 COMPOSITION FOR PRETERM INFANTS TO REDUCE TIME TO FULL ENTERAL FEEDING Final Rejection SOCIETE DES PRODUITS NESTLE S.A.
19363455 METHOD FOR PRODUCING AND PURIFYING RNA, COMPRISING AT LEAST ONE STEP OF TANGENTIAL FLOW FILTRATION Non-Final OA CureVac Manufacturing GmbH
18618449 PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES Final Rejection UNIVERSITY OF SOUTHERN CALIFORNIA
18108327 MOLYBDENUM(0) PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS Non-Final OA Applied Materials, Inc.
17907015 COMPOSITIONS COMPRISING RHAMNOLIPID, ALKYL POLYGLYCOSIDE AND ACYL LACTYLATE Non-Final OA Evonik Operations GmbH
18240151 BIS (ARENE) METAL COMPLEXES AND RELATED METHODS Non-Final OA ENTEGRIS, INC.
18239661 INDENYL PRECURSORS Non-Final OA ENTEGRIS, INC.
18564245 AZEOTROPIC OR QUASI-AZEOTROPIC COMPOSITION COMPRISING CHLOROTRIFLUOROETHYLENE AND/OR 1,1,2-TRIFLUOROETHANE Non-Final OA ARKEMA FRANCE
18276675 IMPROVED PROCESS FOR MANUFACTURING HIGH-PURITY ALKYL ACRYLATES Non-Final OA Arkema France
18328049 Skin Care Compositions and Methods of Use Non-Final OA Colgate-Palmolive Company
18245905 PROCESSES OF PREPARING FERROCENE LIGAND MIXTURES SUITABLE FOR PROPYLENE HYDROFORMYLATION Non-Final OA Eastman Chemical Company
18239460 COMPOSITIONS COMPRISING DECITABINE AND TETRAHYDROURIDINE AND USES THEREOF Non-Final OA The Board of Trustees of the University of Illinois
18695916 POLYETHER POLYMERIZATION PROCESS Non-Final OA Dow Global Technologies LLC
18686783 ISOLATION OF DIALKYLENE PHENOLIC GLYCOL ETHER Non-Final OA Dow Global Technologies LLC
17925107 METHOD FOR THE HYDROSILYLATION OF AN OLEFINIC NITRILE AND A HYDRIDOSILANE Non-Final OA Dow Global Technologies LLC
18291294 STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE Final Rejection AMGEN INC.
18282263 METHOD FOR PRODUCING OXIDE AND METHOD FOR PRODUCING PT/BI COMPOSITE CATALYST Final Rejection KAO CORPORATION
17436023 COMPOSITIONS OF MATTER WITH ACTIVITY TO REMOVE LIPOFUSCIN FROM RETINAL CELLS Non-Final OA Cornell University
17554927 Methods of treating amyloid-beta peptide diseases Non-Final OA Ecole Polytechnique Federale de Lausanne
18041582 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND Final Rejection KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
17312104 Saponin Conjugates Non-Final OA Sapreme Technologies B.V.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month